For more than 15 years, Liming Yuan's legal practice has focused on representing multinational companies in acquisitions and investments in China and China-based clients in acquisitions and investments overseas. He has in-depth experience advising clients in complex and sensitive transactions that have become difficult to resolve, with a particular emphasis on complex issues related to deal structure, regulatory approvals, joint venture, tax, employment, and compliance. Most of the clients Liming represents are in the manufacturing and health care industries.
Liming's representative transactions include: acquisitions of majority or minority equity interests in Chinese state-owned or private companies, sales of all of the China businesses of several Fortune 500 companies, Chinese companies' overseas asset and share acquisitions in the United States and Europe, establishment of more than 30 joint ventures in China between Chinese and foreign shareholders, and U.S. health care institutions' cooperation projects and agreements to provide telemedicine or other health care-related advisory services in China. Companies for which Liming has worked on substantial matters include: Cardinal Health, Parker Hannifin, Delphi, Hyster-Yale, Sherwin-Williams, Staples, General Pacific, Cleveland Clinics, Dignity Health, City of Hope, Sinochem International, Fosun, Wuhan Iron & Steel Company, and China Union Pay.
Liming is fluent in English and a native speaker of Mandarin Chinese. Before moving to the Firm's Shanghai Office in 2006, Liming worked at the Firm's Dallas Office for three years.
Telemedicine Services Reimbursable in Guizhou Province of China, Digital Health Law Update, Vol. II, Issue 5
China's New Regulation on Health Care and Medical Big Data Might Unlock Online Sales of Prescription Drugs, Digital Health Law Update, Vol. II, Issue 4
China Issued New Work Plan to Develop the Digital Health Care and Telemedicine Industry, Digital Health Law Update, Vol. II, Issue 3
- June 28, 2016
Legal Issues Related to Outbound Investments, Suzhou Outbound Seminar hosted by Jiangsu NDRC
- June 16-19, 2016
Comparison of Legal Regulations on Digital Health and Telemedicine in the US and China, 6th Annual Academic Congress of Chinese Society of Digital Medicine & Founding Conference of the International Society of Digital Medicine & 1st International Conference on Digital Medicine and Medical 3D Printing
- January 26, 2016
CLE Academy Shanghai 2016
- July 16, 2014
Anti-Corruption Due Diligence in Cross-Border M&A, The European Chamber Annual M&A Conference
- June 12, 2014
2014首届律商联讯法律高峰论坛 The First Annual LexisNexis Legal Summit - "规制缓和与规制强化双重背景下的公司法务 -- 机遇与挑战"
- April 22, 2014
Jones Day and InterChina M&A Update 2014 - Legal Issues in Recent Restructuring/Divestment Transactions
- March 6, 2014
The European Chamber M&A/PE Committee Event - Deal Structure Issues Arising from Recent M&A Deals
- December 12, 2013
Mergers & Acquisitions Due Diligence Conference 2013 - Anti-Corruption Due Diligence in Cross-Border M&A
- October 18, 2013
Jones Day and InterChina M&A Networking Event - Deal Structure Issues Arising from Recent M&A Deals
- October 25, 2012
China Inbound Seminar: New Challenges and Opportunities for Foreign Investments in China
- October 23, 2012
Life Science Legal Drama - "Mr. Big in Wonderland"
- Georgetown University (LL.M. in Taxation with distinction 2003; Georgetown Fellow at Council On State Taxation); University of Arkansas at Little Rock (J.D. 2002); Beijing Second Foreign Languages University (B.A. 1998)
- District of Columbia
- Asian Legal Business: ALB 2015 Client Choice Top 20 Lawyers in China
- English, Mandarin